The role of mitochondria in inherited neurodegenerative diseases

Journal of Neurochemistry

Volumn 97, Issue 6, 2006, Pages 1659-1675

  Kwong, Jennifer Q ^a   Beal, M Flint ^a   Manfredi, Giovanni ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Huntington's disease; Mitochondria; Neurodegeneration; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; GLUTATHIONE TRANSFERASE; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; AUTOPHOSPHORYLATION; BRAIN MITOCHONDRION; CLINICAL FEATURE; DEGENERATIVE DISEASE; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENZYME LOCALIZATION; EXCITOTOXICITY; GENETIC POLYMORPHISM; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL RESPIRATION; NARP SYNDROME; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SYNAPTIC MEMBRANE; TRANSCRIPTION TERMINATION; UPREGULATION;

ANIMALS; HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS; MITOCHONDRIA;

ATAXIA;

EID: 33745028132     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03990.x     Document Type: Review

References (199)

1. Alexander C. Votruba M. Pesch U. E. et al. 2000 OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 26, 211 215.
2. Anandatheerthavarada H. K. Biswas G. Robin M. A. Avadhani N. G. 2003 Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 41 54.
3. Anderson S. Bankier A. T. Barrell B. G. et al. 1981 Sequence and organization of the human mitochondrial genome. Nature 290, 457 465.
4. Ankarcrona M. Hultenby K. 2002 Presenilin-1 is located in rat mitochondria. Biochem. Biophys. Res. Commun. 295, 766 770.
5. Arnold I. Langer T. 2002 Membrane protein degradation by AAA proteases in mitochondria. Biochim. Biophys. Acta 1592, 89 96.
6. Atorino L. Silvestri L. Koppen M. Cassina L. Ballabio A. Marconi R. Langer T. Casari G. 2003 Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J. Cell Biol. 163, 777 787.
7. Autere J. Moilanen J. S. Finnila S. Soininen H. Mannermaa A. Hartikainen P. Hallikainen M. Majamaa K. 2004 Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia. Hum. Genet. 115, 29 35.
8. Babcock M. de Silva D. Oaks R. Davis-Kaplan S. Jiralerspong S. Montermini L. Pandolfo M. Kaplan J. 1997 Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276, 1709 1712.
9. Bach D. Pich S. Soriano F. X. et al. 2003 Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278, 17 190 17 197.
10. Bae B. I. Xu H. Igarashi S. et al. 2005 p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47, 29 41.
11. Beal M. F. Brouillet E. Jenkins B. Henshaw R. Rosen B. Hyman B. T. 1993 Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61, 1147 1150.
12. Bender A. Krishnan K. J. Morris C. M. et al. 2006 High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38, 515 517.
13. Beretta S. Mattavelli L. Sala G. Tremolizzo L. Schapira A. H. Martinuzzi A. Carelli V. Ferrarese C. 2004 Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain 127, 2183 2192.
14. Beretta S. Sala G. Mattavelli L. Ceresa C. Casciati A. Ferri A. Carri M. T. Ferrarese C. 2003 Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. Neurobiol. Dis. 13, 213 221.
15. Betarbet R. Sherer T. B. Greenamyre J. T. 2005 Ubiquitin-proteasome system and Parkinson's diseases. Exp Neurol. 191, S17 S27.
16. Betarbet R. Sherer T. B. MacKenzie G. Garcia-Osuna M. Panov A. V. Greenamyre J. T. 2000 Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301 1306.
17. Bonifati V. Rizzu P. van Baren M. J. et al. 2003 Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256 259.
18. Brown M. D. Starikovskaya E. Derbeneva O. Hosseini S. Allen J. C. Mikhailovskaya I. E. Sukernik R. I. Wallace D. C. 2002 The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup. J. Hum. Genet. 110, 130 138.
19. Browne S. E. Bowling A. C. MacGarvey U. Baik M. J. Berger S. C. Muqit M. M. Bird E. D. Beal M. F. 1997 Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646 653.
20. Bubber P. Haroutunian V. Fisch G. Blass J. P. Gibson G. E. 2005 Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann. Neurol. 57, 695 703.
21. Bulteau A. L. O'Neill H. A. Kennedy M. C. Ikeda-Saito M. Isaya G. Szweda L. I. 2004 Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305, 242 245.
22. Busciglio J. Pelsman A. Wong C. Pigino G. Yuan M. Mori H. Yankner B. A. 2002 Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33, 677 688.
23. Campuzano V. Montermini L. Lutz Y. et al. 1997 Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 6, 1771 1780.
24. Campuzano V. Montermini L. Molto M. D. et al. 1996 Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423 1427.
25. Canet-Aviles R. M. Wilson M. A. Miller D. W. Ahmad R. McLendon C. Bandyopadhyay S. Baptista M. J. Ringe D. Petsko G. A. Cookson M. R. 2004 The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U.S.A. 101, 9103 9108.
26. Carelli V. Giordano C. d'Amati G. 2003 Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet. 19, 257 262.
27. Carelli V. Rugolo M. Sgarbi G. Ghelli A. Zanna C. Baracca A. Lenaz G. Napoli E. Martinuzzi A. Solaini G. 2004 Bioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: a model of mitochondrial neurodegeneration. Biochim. Biophys. Acta 1658, 172 179.
28. Carri M. T. Ferri A. Battistoni A. Famhy L. Gabbianelli R. Poccia F. Rotilio G. 1997 Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 414, 365 368.
29. Casari G. De Fusco M. Ciarmatori S. et al. 1998 Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93, 973 983.
30. Casley C. S. Canevari L. Land J. M. Clark J. B. Sharpe M. A. 2002 Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80, 91 100.
31. Caspersen C. Wang N. Yao J. Sosunov A. Chen X. Lustbader J. W. Xu H. W. Stern D. McKhann G. Yan S. D. 2005 Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19, 2040 2041.
32. Chang D. T. Rintoul G. L. Pandipati S. Reynolds I. J. 2006 Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol. Dis. 22, 388 400.
33. Chen H. Chan D. C. 2005 Emerging functions of mammalian mitochondrial fusion and fission. Hum. Mol. Genet. 14, Suppl. 2, R283 R289.
34. Chinnery P. F. Brown D. T. Andrews R. M. Singh-Kler R. Riordan-Eva P. Lindley J. Applegarth D. A. Turnbull D. M. Howell N. 2001 The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy. Brain 124, 209 218.
35. Choo Y. S. Johnson G. V. MacDonald M. Detloff P. J. Lesort M. 2004 Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13, 1407 1420.
36. Cong S. Y. Pepers B. A. Evert B. O. Rubinsztein D. C. Roos R. A. van Ommen G. J. Dorsman J. C. 2005 Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci. 30, 560 571.
37. Cooper J. K. Schilling G. Peters M. F. et al. 1998 Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7, 783 790.
38. Corral-Debrinski M. Horton T. Lott M. T. Shoffner J. M. Beal M. F. Wallace D. C. 1992 Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat. Genet. 2, 324 329.
39. Crouch P. J. Blake R. Duce J. A. et al. 2005 Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J. Neurosci. 25, 272 279.
40. Dal Canto M. C. 1995 Comparison of pathological alterations in ALS and a murine transgenic model: pathogenetic implications. Clin. Neurosci. 3, 332 337.
41. Dal Canto M. C. Gurney M. E. 1994 Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol 145, 1271 1279.
42. Damiano M. Starkov A. A. Petri S. Kipiani K. Kiaei M. Mattiazzi M. Flint Beal M. Manfredi G. 2006 Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J. Neurochem. 96, 1349 1361.
43. Danial N. N. Korsmeyer S. J. 2004 Cell death: critical control points. Cell 116, 205 219.
44. Darios F. Corti O. Lucking C. B. et al. 2003 Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12, 517 526.
45. Dauer W. Kholodilov N. Vila M. et al. 2002 Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl. Acad. Sci. U.S.A. 99, 14 524 14 529.
46. Delettre C. Lenaers G. Griffoin J. M. et al. 2000 Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26, 207 210.
47. DiMauro S. Hirano M. 2005 Mitochondrial encephalomyopathies: an update. Neuromuscul. Disord. 15, 276 286.
48. Dunah A. W. Jeong H. Griffin A. Kim Y. M. Standaert D. G. Hersch S. M. Mouradian M. M. Young A. B. Tanese N. Krainc D. 2002 Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238 2243.
49. Durr A. Cossee M. Agid Y. Campuzano V. Mignard C. Penet C. Mandel J. L. Brice A. Koenig M. 1996 Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335, 1169 1175.
50. Edbauer D. Winkler E. Regula J. T. Pesold B. Steiner H. Haass C. 2003 Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486 488.
51. Fink J. K. 2003 The hereditary spastic paraplegias: nine genes and counting. Arch. Neurol. 60, 1045 1049.
52. Floreani M. Napoli E. Martinuzzi A. Pantano G. De Riva V. Trevisan R. Bisetto E. Valente L. Carelli V. Dabbeni-Sala F. 2005 Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy. FEBS J. 272, 1124 1135.
53. Foury F. Cazzalini O. 1997 Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett. 411, 373 377.
54. Gakh O. Park S. Liu G. Macomber L. Imlay J. A. Ferreira G. C. Isaya G. 2006 Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum. Mol. Genet. 15, 467 479.
55. Ghadge G. D. Lee J. P. Bindokas V. P. Jordan J. Ma L. Miller R. J. Roos R. P. 1997 Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17, 8756 8766.
56. Goebel H. H. Heipertz R. Scholz W. Iqbal K. Tellez-Nagel I. 1978 Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies. Neurology 28, 23 31.
57. Goedert M. 2001 Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492 501.
58. Grabczyk E. Usdin K. 2000 The GAA*TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner. Nucl. Acids Res. 28, 2815 2822.
59. Greene J. C. Whitworth A. J. Kuo I. Andrews L. A. Feany M. B. Pallanck L. J. 2003 Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U.S.A. 100, 4078 4083.
60. Greene J. C. Whitworth A. J. Andrews L. A. Parker T. J. Pallanck L. J. 2005 Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum. Mol. Genet. 14, 799 811.
61. Hansen J. J. Durr A. Cournu-Rebeix I. et al. 2002 Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am. J. Hum. Genet. 70, 1328 1332.
62. Hansson C. A. Frykman S. Farmery M. R. et al. 2004 Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J. Biol. Chem. 279, 51 654 51 660.
63. Harding A. E. 1981 Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104, 589 620.
64. Harman D. 1957 Prolongation of the normal life span by radiation protection chemicals. J. Gerontol. 12, 257 263.
65. Hausse A. O. Aggoun Y. Bonnet D. Sidi D. Munnich A. Rotig A. Rustin P. 2002 Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart 87, 346 349.
66. Hazeki N. Nakamura K. Goto J. Kanazawa I. 1999 Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract. Biochem. Biophys. Res. Commun. 256, 361 366.
67. He X. Y. Wen G. Y. Merz G. Lin D. Yang Y. Z. Mehta P. Schulz H. Yang S. Y. 2002 Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. Brain Res. Mol. Brain Res. 99, 46 53.
68. Healy D. G. Abou-Sleiman P. M. Casas J. P. et al. 2006 UCHL-1 is not a Parkinson's disease susceptibility gene. Ann. Neurol. 59, 627 633.
69. Higgins C. M. Jung C. Ding H. Xu Z. 2002 Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J Neurosci. 22, RC215.
70. Higgins C. M. Jung C. Xu Z. 2003 ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci. 4, 16.
71. Hofmann S. Jaksch M. Bezold R. Mertens S. Aholt S. Paprotta A. Gerbitz K. D. 1997 Population genetics and disease susceptibility: characterization of central European haplogroups by mtDNA gene mutations, correlation with D loop variants and association with disease. Hum. Mol. Genet. 6, 1835 1846.
72. Holt I. J. Harding A. E. Petty R. K. Morgan-Hughes J. A. 1990 A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. HumGenet. 46, 428 433.
73. Honda S. Aihara T. Hontani M. Okubo K. Hirose S. 2005 Mutational analysis of action of mitochondrial fusion factor mitofusin-2. J. Cell Sci. 118, 3153 3161.
74. Houstek J. Klement P. Hermanska J. Houstkova H. Hansikova H. Van den Bogert C. Zeman J. 1995 Altered properties of mitochondrial ATP-synthase in patients with a T→G mutation in the ATPase 6 (subunit a) gene at position 8993 of mtDNA. Biochim. Biophys. Acta 1271, 349 357.
75. Howell N. Bindoff L. A. McCullough D. A. Kubacka I. Poulton J. Mackey D. Taylor L. Turnbull D. M. 1991 Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am. J. Hum. Genet. 49, 939 950.
76. Hsu L. J. Sagara Y. Arroyo A. Rockenstein E. Sisk A. Mallory M. Wong J. Takenouchi T. Hashimoto M. Masliah E. 2000 alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol 157, 401 410.
77. Huang H. M. Zhang H. Xu H. Gibson G. E. 2003 Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation. Biochim. Biophys. Acta 1637, 119 126.
78. Inoue H. Tsukita K. Iwasato T. et al. 2003 The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. EMBO J. 22, 6665 6674.
79. Ito S. Ohta S. Nishimaki K. Kagawa Y. Soma R. Kuno S. Y. Komatsuzaki Y. Mizusawa H. Hayashi J. 1999 Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 96, 2099 2103.
80. Jenkins B. G. Koroshetz W. J. Beal M. F. Rosen B. R. 1993 Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43, 2689 2695.
81. Jung C. Higgins C. M. Xu Z. 2002 Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J. Neurochem. 83, 535 545.
82. Kelly D. P. Scarpulla R. C. 2004 Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18, 357 368.
83. Kim R. H. Smith P. D. Aleyasin H. et al. 2005 Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 102, 5215 5220.
84. Kirkinezos I. G. Bacman S. R. Hernandez D. Oca-Cossio J. Arias L. J. Perez-Pinzon M. A. Bradley W. G. Moraes C. T. 2005 Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J. Neurosci. 25, 164 172.
85. Kish S. J. Bergeron C. Rajput A. Dozic S. Mastrogiacomo F. Chang L. J. Wilson J. M. DiStefano L. M. Nobrega J. N. 1992 Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59, 776 779.
86. Kitada T. Asakawa S. Hattori N. Matsumine H. Yamamura Y. Minoshima S. Yokochi M. Mizuno Y. Shimizu N. 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605 608.
87. Klivenyi P. Siwek D. Gardian G. Yang L. Starkov A. Cleren C. Ferrante R. J. Kowall N. W. Abeliovich A. Beal M. F. 2006 Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol. Dis 21, 541 548.
88. Kong J. Xu Z. 1998 Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18, 3241 3250.
89. Koroshetz W. J. Jenkins B. G. Rosen B. R. Beal M. F. 1997 Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann. Neurol. 41, 160 165.
90. Kostic V. Jackson-Lewis V. de Bilbao F. Dubois-Dauphin M. Przedborski S. 1997 Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559 562.
91. Kraytsberg Y. Kudryavtseva E. McKee A. C. Geula C. Kowall N. W. Khrapko K. 2006 Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 38, 518 520.
92. Kruman I. I. Pedersen W. A. Springer J. E. Mattson M. P. 1999 ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol. 160, 28 39.
93. Kuemmerle S. Gutekunst C. A. Klein A. M. Li X. J. Li S. H. Beal M. F. Hersch S. M. Ferrante R. J. 1999 Huntington aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46, 842 849.
94. Kuroda Y. Mitsui T. Kunishige M. Shono M. Akaike M. Azuma H. Matsumoto T. 2006 Parkin enhances mitochondrial biogenesis in proliferating cells. Hum. Mol. Genet. 15, 883 895.
95. Langston J. W. Ballard P. Tetrud J. W. Irwin I. 1983 Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979 980.
96. Lee J. Kim C. H. Simon D. K. et al. 2005 Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. J. Biol. Chem. 280, 40 398 40 401.
97. Leigh D. 1951 Subacute necrotizing encephalomyelopathy in an infant. J. Neurol. Neurosurg Psychiatry 14, 216 221.
98. Leroy E. Boyer R. Auburger G. et al. 1998 The ubiquitin pathway in Parkinson's disease. Nature 395, 451 452.
99. Li S. H. Cheng A. L. Zhou H. Lam S. Rao M. Li H. Li X. J. 2002 Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell Biol. 22, 1277 1287.
100. Li Z. Okamoto K. Hayashi Y. Sheng M. 2004 The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873 887.
101. Li M. Ona V. O. Guegan C. et al. 2000 Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335 339.
102. Lin M. T. Simon D. K. Ahn C. H. Kim L. M. Beal M. F. 2002 High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11, 133 145.
103. Lin J. Wu P. H. Tarr P. T. et al. 2004 Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119, 121 135.
104. Liu J. Lillo C. Jonsson P. A. et al. 2004 Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43, 5 17.
105. Lopez M. F. Kristal B. S. Chernokalskaya E. Lazarev A. Shestopalov A. I. Bogdanova A. Robinson M. 2000 High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis 21, 3427 3440.
106. Ludolph A. C. He F. Spencer P. S. Hammerstad J. Sabri M. 1991 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492 498.
107. Luoma P. Melberg A. Rinne J. O. et al. 2004 Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364, 875 882.
108. Lustbader J. W. Cirilli M. Lin C. et al. 2004 ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448 452.
109. Manczak M. Anekonda T. S. Henson E. Park B. S. Quinn J. Reddy P. H. 2006 Mitochondria are a direct site of A{beta} accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437 1449.
110. Manfredi G. Gupta N. Vazquez-Memije M. E. Sadlock J. E. Spinazzola A. De Vivo D. C. Schon E. A. 1999 Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J. Biol. Chem. 274, 9386 9391.
111. Martin L. J. Pan Y. Price A. C. Sterling W. Copeland N. G. Jenkins N. A. Price D. L. Lee M. K. 2006 Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26, 41 50.
112. Martins L. M. Morrison A. Klupsch K. et al. 2004 Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell Biol. 24, 9848 9862.
113. Mattiazzi M. D'Aurelio M. Gajewski C. D. Martushova K. Kiaei M. Beal M. F. Manfredi G. 2002 Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 277, 29 626 29 633.
114. Mattiazzi M. Vijayvergiya C. Gajewski C. D. DeVivo D. C. Lenaz G. Wiedmann M. Manfredi G. 2004 The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum. Mol. Genet. 13, 869 879.
115. Meade C. A. Deng Y. P. Fusco F. R. Del Mar. N. Hersch S. Goldowitz D. Reiner A. 2002 Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J. Comp. Neurol. 449, 241 269.
116. Mena M. A. Khan U. Togasaki D. M. Sulzer D. Epstein C. J. Przedborski S. 1997 Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J. Neurochem. 69, 21 33.
117. Menzies F. M. Cookson M. R. Taylor R. W. Turnbull D. M. Chrzanowska-Lightowlers Z. M. Dong L. Figlewicz D. A. Shaw P. J. 2002 Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 125, 1522 1533.
118. Mitsumoto A. Nakagawa Y. 2001 DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic. Res. 35, 885 893.
119. Muftuoglu M. Elibol B. Dalmizrak O. Ercan A. Kulaksiz G. Ogus H. Dalkara T. Ozer N. 2004 Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov. Disord. 19, 544 548.
120. Mulder D. W. Kurland L. T. 1987 Motor neuron disease: epidemiologic studies. Adv. Exp. Med. Biol. 209, 325 332.
121. Mutisya E. M. Bowling A. C. Beal M. F. 1994 Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63, 2179 2184.
122. Nicholls D. G. Vesce S. Kirk L. Chalmers S. 2003 Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 34, 407 424.
123. Nicklas W. J. Vyas I. Heikkila R. E. 1985 Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36, 2503 2508.
124. Nolden M. Ehses S. Koppen M. Bernacchia A. Rugarli E. I. Langer T. 2005 The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 123, 277 289.
125. Nunomura A. Perry G. Aliev G. et al. 2001 Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759 767.
126. Okado-Matsumoto A. Fridovich I. 2001 Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J. Biol. Chem. 276, 38 388 38 393.
127. Okado-Matsumoto A. Fridovich I. 2002 Amyotrophic lateral sclerosis: a proposed mechanism. Proc. Natl. Acad. Sci. U.S.A. 99, 9010 9014.
128. Olichon A. Emorine L. J. Descoins E. et al. 2002 The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett. 523, 171 176.
129. Onyango I. G. Bennett J. P. Jr. Tuttle J. B. 2005 Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids. Neurobiol. Dis. 19, 312 322.
130. Palacino J. J. Sagi D. Goldberg M. S. Krauss S. Motz C. Wacker M. Klose J. Shen J. 2004 Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279, 18 614 18 622.
131. Panov A. V. Gutekunst C. A. Leavitt B. R. Hayden M. R. Burke J. R. Strittmatter W. J. Greenamyre J. T. 2002 Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731 736.
132. Parker W. D. Jr. Mahr N. J. Filley C. M. Parks J. K. Hughes D. Young D. A. Cullum C. M. 1994 Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44, 1086 1090.
133. Pasinelli P. Belford M. E. Lennon N. Bacskai B. J. Hyman B. T. Trotti D. Brown R. H. Jr. 2004 Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43, 19 30.
134. Pesah Y. Pham T. Burgess H. Middlebrooks B. Verstreken P. Zhou Y. Harding M. Bellen H. Mardon G. 2004 Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131, 2183 2194.
135. Petit A. Kawarai T. Paitel E. et al. 2005 Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280, 34 025 34 032.
136. Polymeropoulos M. H. Lavedan C. Leroy E. et al. 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045 2047.
137. Puccio H. Simon D. Cossee M. Criqui-Filipe P. Tiziano F. Melki J. Hindelang C. Matyas R. Rustin P. Koenig M. 2001 Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet. 27, 181 186.
138. Puigserver P. Spiegelman B. M. 2003 Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24, 78 90.
139. Pyle A. Foltynie T. Tiangyou W. et al. 2005 Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann. Neurol. 57, 564 567.
140. Rabizadeh S. Gralla E. B. Borchelt D. R. Gwinn R. Valentine J. S. Sisodia S. Wong P. Lee M. Hahn H. Bredesen D. E. 1995 Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. U.S.A. 92, 3024 3028.
141. Ristow M. Mulder H. Pomplun D. et al. 2003 Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J. Clin. Invest. 112, 527 534.
142. Rosen D. R. Siddique T. Patterson D. Figlewicz D. A. Sapp P. Hentati A. Donaldson D. Goto J. O'Regan J. P. Deng H. X. et al. 1993 Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59 62.
143. Rothstein J. D. 1996 Excitotoxicity hypothesis. Neurology 47, S19 S25 discussion S26.
144. Rustin P. von Kleist-Retzow J. C. Chantrel-Groussard K. Sidi D. Munnich A. Rotig A. 1999 Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354, 477 479.
145. Sakamoto N. Chastain P. D. Parniewski P. Ohshima K. Pandolfo M. Griffith J. D. Wells R. D. 1999 Sticky DNA: Self-Assocation properties of Long EAA. TCC repeats in R.R.Y triplex strutures from Friedreich's ataxia. Mol. Cell 4, 465 475.
146. Santel A. Fuller M. T. 2001 Control of mitochondrial morphology by a human mitofusin. J. Cell Sci. 114, 867 874.
147. Schulz J. B. Dehmer T. Schols L. et al. 2000 Oxidative stress in patients with Friedreich ataxia. Neurology 55, 1719 1721.
148. Seong I. S. Ivanova E. Lee J. M. et al. 2005 HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum. Mol. Genet. 14, 2871 2880.
149. Seznec H. Simon D. Bouton C. et al. 2005 Friedreich ataxia: the oxidative stress paradox. Hum. Mol. Genet. 14, 463 474.
150. Shimura H. Hattori N. Kubo S. et al. 2000 Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302 305.
151. Shinder G. A. Lacourse M. C. Minotti S. Durham H. D. 2001 Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 276, 12 791 12 796.
152. Shirane M. Nakayama K. I. 2003 Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat. Cell Biol. 5, 28 37.
153. Silvestri L. Caputo V. Bellacchio E. Atorino L. Dallapiccola B. Valente E. M. Casari G. 2005 Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14, 3477 3492.
154. Simon D. K. Pulst S. M. Sutton J. P. Browne S. E. Beal M. F. Johns D. R. 1999 Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 53, 1787 1793.
155. Simon D. K. Mayeux R. Marder K. Kowall N. W. Beal M. F. Johns D. R. 2000 Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurology 54, 703 709.
156. Simon D. Seznec H. Gansmuller A. Carelle N. Weber P. Metzger D. Rustin P. Koenig M. Puccio H. 2004 Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J. Neurosci. 24, 1987 1995.
157. Simonetti S. Chen X. DiMauro S. Schon E. A. 1992 Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim. Biophys. Acta 1180, 113 122.
158. Smith W. W. Pei Z. Jiang H. Moore D. J. Liang Y. West A. B. Dawson V. L. Dawson T. M. Ross C. A. 2005 Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 102, 18 676 18 681.
159. Song D. D. Shults C. W. Sisk A. Rockenstein E. Masliah E. 2004 Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186, 158 172.
160. Soong N. W. Hinton D. R. Cortopassi G. Arnheim N. 1992 Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat. Genet. 2, 318 323.
161. Stokin G. B. Lillo C. Falzone T. L. et al. 2005 Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282 1288.
162. Strauss K. M. Martins L. M. Plun-Favreau H. et al. 2005 Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099 2111.
163. Sturtz L. A. Diekert K. Jensen L. T. Lill R. Culotta V. C. 2001 A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J. Biol. Chem. 276, 38 084 38 089.
164. Suzuki Y. Imai Y. Nakayama H. Takahashi K. Takio K. Takahashi R. 2001 A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8, 613 621.
165. Tabrizi S. J. Cleeter M. W. Xuereb J. Taanman J. W. Cooper J. M. Schapira A. H. 1999 Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann. Neurol. 45, 25 32.
166. Taira T. Saito Y. Niki T. Iguchi-Ariga S. M. Takahashi K. Ariga H. 2004 DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5, 213 218.
167. Takeuchi H. Kobayashi Y. Ishigaki S. Doyu M. Sobue G. 2002 Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis. J. Biol. Chem. 277, 50 966 50 972.
168. Takuma K. Yao J. Huang J. Xu H. Chen X. Luddy J. Trillat A. C. Stern D. M. Arancio O. Yan S. S. 2005 ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J. 19, 597 598.
169. Tao X. Tong L. 2003 Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. J. Biol. Chem. 278, 31 372 31 379.
170. Tatuch Y. Robinson B. H. 1993 The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem. Biophys. Res. Commun. 192, 124 128.
171. Tatuch Y. Christodoulou J. Feigenbaum A. Clarke J. T. Wherret J. Smith C. Rudd N. Petrova-Benedict R. Robinson B. H. 1992 Heteroplasmic mtDNA mutation (T - G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am. J. Hum. Genet. 50, 852 858.
172. The Huntington's Disease Collaborative Research Group 1993 A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Dis Collaborative Res. Group. Cell 72, 971 983.
173. Thierbach R. Schulz T. J. Isken F. et al. 2005 Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum. Mol. Genet. 14, 3857 3864.
174. Thyagarajan D. Bressman S. Bruno C. Przedborski S. Shanske S. Lynch T. Fahn S. DiMauro S. 2000 A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann. Neurol. 48, 730 736.
175. Torroni A. Petrozzi M. D'Urbano L. et al. 1997 Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am. J. Hum. Genet. 60, 1107 1121.
176. Trounce I. Neill S. Wallace D. C. 1994 Cytoplasmic transfer of the mtDNA nt 8993 T→G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proc. Natl. Acad. Sci. U.S.A. 91, 8334 8338.
177. Tsao K. Aitken P. A. Johns D. R. 1999 Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy. Br. J. Ophthalmol. 83, 577 581.
178. Valente E. M. Abou-Sleiman P. M. Caputo V. et al. 2004 Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158 1160.
179. Vazquez-Memije M. E. Shanske S. Santorelli F. M. Kranz-Eble P. Davidson E. DeVivo D. C. DiMauro S. 1996 Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J. Inherit. Metab. Dis. 19, 43 50.
180. Vijayvergiya C. Beal M. F. Buck J. Manfredi G. 2005 Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J. Neurosci. 25, 2463 2470.
181. Vives-Bauza C. Andreu A. L. Manfredi G. Beal M. F. Janetzky B. Gruenewald T. H. Lin M. T. 2002 Sequence analysis of the entire mitochondrial genome in Parkinson's disease. Biochem. Biophys. Res. Commun. 290, 1593 1601.
182. Volles M. J. Lansbury P. T. Jr. 2002 Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41, 4595 4602.
183. Wallace D. C. Singh G. Lott M. T. Hodge J. A. Schurr T. G. Lezza A. M. Elsas L. J. 2nd and Nikoskelainen E. K. 1988 Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242, 1427 1430.
184. van der Walt J. M. Nicodemus K. K. Martin E. R. et al. 2003 Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72, 804 811.
185. Wang G. J. Jackson J. G. Thayer S. A. 2003 Altered distribution of mitochondria impairs calcium homeostasis in rat hippocampal neurons in culture. J. Neurochem. 87, 85 94.
186. Wang H. Q. Du Nakaya Y. Z. Yamane T. Shirane M. Kudo T. Takeda M. Takebayashi K. Noda Y. Nakayama K. I. Nishimura M. 2005 Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2. Hum. Mol. Genet. 14, 1889 1902.
187. Weisiger R. A. Fridovich I. 1973 Superoxide dismutase. Organelle specificity. J. Biol. Chem. 248, 3582 3592.
188. West A. B. Moore D. J. Biskup S. Bugayenko A. Smith W. W. Ross C. A. Dawson V. L. Dawson T. M. 2005 Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. U.S.A. 102, 16 842 16 847.
189. Whitworth A. J. Theodore D. A. Greene J. C. Benes H. Wes P. D. Pallanck L. J. 2005 Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 102, 8024 8029.
190. Wong P. C. Pardo C. A. Borchelt D. R. Lee M. K. Copeland N. G. Jenkins N. A. Sisodia S. S. Cleveland D. W. Price D. L. 1995 An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105 1116.
191. Wong A. Yang J. Cavadini P. Gellera C. Lonnerdal B. Taroni F. Cortopassi G. 1999 The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet. 8, 425 430.
192. Yan S. D. Fu J. Soto C. et al. 1997 An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389, 689 695.
193. Yang Y. Gehrke S. Haque M. E. et al. 2005 Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. U.S.A. 102, 13 670 13 675.
194. Zhang L. Shimoji M. Thomas B. et al. 2005 Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 14, 2063 2073.
195. Zhu S. Stavrovskaya I. G. Drozda M. et al. 2002 Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74 78.
196. Zimprich A. Biskup S. Leitner P. et al. 2004 Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601 607.
197. Zsurka G. Kalman J. Csaszar A. Rasko I. Janka Z. Venetianer P. 1998 No mitochondrial haplotype was found to increase risk for Alzheimer's disease. Biol. Psychiatry 44, 371 373.
198. Zuchner S. Mersiyanova I. V. Muglia M. et al. 2004 Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 36, 449 451.
199. Zuchner S. De Jonghe P. Jordanova A. et al. 2006 Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann. Neurol. 59, 276 281.